Product Information
DOXYCYCLINE HYCLATE 150 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $0.7243 per EA under NDC 62135090820. Its NADAC has been published 43 times since Dec 10, 2025.
FDA first approved this application on Jul 25, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Chartwell RX LLCNDC
62135090820
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINE HYCLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA205931FDA Approved
7/25/2014
TE Code
AB
On Market Since
7/25/2014
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE HYCLATE 150 MG TAB has been published 43 times since Dec 10, 2025, and over the history we have for it it has declined 18.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7243 per EA |
|---|---|
| All-time high | $0.9134 (Jun 10, 2026) |
| All-time low | $0.6934 (Jun 17, 2026) |
| 52-week high | $0.9134 |
| 52-week low | $0.6934 |
| Median price | $0.9134 |
| Average price | $0.8372 |
| Largest weekly change | -24.1% (Jun 17, 2026) |
| Weeks tracked | 43 |
| Tracking since | Dec 10, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxycycline Hyclate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE HYCLATE 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE HYCLATE 150 MG TAB, manufactured by Chartwell RX LLC, is $0.7243 per EA (NDC 62135090820), effective Sep 30, 2026.
How has the price of DOXYCYCLINE HYCLATE 150 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE HYCLATE 150 MG TAB has declined 18.7%. It has been tracked across 43 weekly CMS publications since Dec 10, 2025.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE HYCLATE 150 MG TAB?
Since Dec 10, 2025, the NADAC for DOXYCYCLINE HYCLATE 150 MG TAB has ranged from a low of $0.6934 (Jun 17, 2026) to a high of $0.9134 (Jun 10, 2026), with a median of $0.9134 per EA.
Are there cheaper alternatives to DOXYCYCLINE HYCLATE 150 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXYCYCLINE HYCLATE 150 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXYCYCLINE HYCLATE 150 MG TAB?
DOXYCYCLINE HYCLATE 150 MG TAB (NDC 62135090820) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.